Clorox's second-quarter fiscal year 2026 results were generally in line with expectations, with net sales decreasing 1% to $1.67 billion and diluted EPS decreasing 16% to $1.29. The company reaffirmed its fiscal year outlook, emphasizing continued progress on strategic priorities and the acquisition of GOJO Industries.
Net sales decreased 1% to $1.67 billion, primarily due to lower consumption, partially offset by shipments ahead of consumption for some businesses.
Gross margin decreased 60 basis points to 43.2%, mainly driven by higher manufacturing and logistics costs, partially offset by cost savings.
Diluted net earnings per share (diluted EPS) decreased 16% to $1.29, impacted by lapping cyberattack insurance recoveries and lower costs from digital capabilities investments.
Adjusted EPS decreased 10% to $1.39, primarily due to lapping prior period tax rate benefits and lower gross profit.
Clorox is maintaining its full-year fiscal 2026 outlook for net sales, gross margin, and adjusted EPS, with expectations at the lower end of the range due to prior order fulfillment challenges. This outlook does not include the impact of the GOJO Industries acquisition.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance